Background The number of older adults has been constantly growing around the globe.
Consequently, multimorbidity and related polypharmacy have become an increasing …

“Frailty” is a term used to refer to a state characterized by enhanced vulnerability to, and
impaired recovery from, stressors compared with a nonfrail state, which is increasingly …

Objective The task force of the International Conference of Frailty and Sarcopenia Research
(ICFSR) developed these clinical practice guidelines to overview the current evidence-base …

In the general population, the use of prescription drugs increases with age. European data
show that 46% of the European population in the age group 45–54 years use prescribed …

Polypharmacy characterizes ongoing prescription of multiple medications in a patient.
Following the demographic change and growing number of elderly patients, polypharmacy …

Abstract Purpose of Review This review identifies exercise-based recommendations to
prevent and manage frailty and fragility fractures from current clinical practice guidelines. We …

Polypharmacy is a prevalent issue in older adults, associated with a wide range of adverse
health outcomes, amplified in those with frailty. This review aims to synthesize current …

Frailty is a geriatric condition associated with increased vulnerability to adverse drug events
and medication-related harm. Existing clinical practice guidelines rarely provide medication …

Background Frailty is increasingly reported among older adults with cardiovascular diseases
and it has been demonstrated to increase negative health outcomes and mortality. To date …

Background: Polypharmacy has become a global health problem and is associated with
adverse health outcomes in the elderly. This study evaluated the prevalence of …